Cytokinetics (CYTK) Change in Acquisitions & Divestments (2016 - 2025)
Historic Change in Acquisitions & Divestments for Cytokinetics (CYTK) over the last 15 years, with Q4 2024 value amounting to $233.3 million.
- Cytokinetics' Change in Acquisitions & Divestments rose 6112.25% to $233.3 million in Q4 2024 from the same period last year, while for Dec 2024 it was $744.2 million, marking a year-over-year decrease of 1454.58%. This contributed to the annual value of $744.2 million for FY2024, which is 1454.58% down from last year.
- As of Q4 2024, Cytokinetics' Change in Acquisitions & Divestments stood at $233.3 million, which was up 6112.25% from $170.0 million recorded in Q3 2024.
- In the past 5 years, Cytokinetics' Change in Acquisitions & Divestments registered a high of $284.4 million during Q2 2023, and its lowest value of $40.2 million during Q3 2020.
- Over the past 5 years, Cytokinetics' median Change in Acquisitions & Divestments value was $140.4 million (recorded in 2022), while the average stood at $144.5 million.
- Its Change in Acquisitions & Divestments has fluctuated over the past 5 years, first skyrocketed by 21943.35% in 2021, then crashed by 4177.9% in 2024.
- Over the past 5 years, Cytokinetics' Change in Acquisitions & Divestments (Quarter) stood at $99.2 million in 2020, then dropped by 2.49% to $96.7 million in 2021, then soared by 63.04% to $157.6 million in 2022, then fell by 8.15% to $144.8 million in 2023, then soared by 61.12% to $233.3 million in 2024.
- Its Change in Acquisitions & Divestments stands at $233.3 million for Q4 2024, versus $170.0 million for Q3 2024 and $165.6 million for Q2 2024.